These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 14742907)
41. Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation. Oyama R; Yamamoto H; Titani K Biochim Biophys Acta; 2000 Jun; 1479(1-2):91-102. PubMed ID: 11004532 [TBL] [Abstract][Full Text] [Related]
42. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization. Teng E; Taylor K; Bilousova T; Weiland D; Pham T; Zuo X; Yang F; Chen PP; Glabe CG; Takacs A; Hoffman DR; Frautschy SA; Cole GM Neurobiol Dis; 2015 Oct; 82():552-560. PubMed ID: 26369878 [TBL] [Abstract][Full Text] [Related]
43. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease. Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791 [TBL] [Abstract][Full Text] [Related]
44. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842 [TBL] [Abstract][Full Text] [Related]
45. Development of DNA aptamers targeting low-molecular-weight amyloid-β peptide aggregates in vitro. Chakravarthy M; AlShamaileh H; Huang H; Tannenberg RK; Chen S; Worrall S; Dodd PR; Veedu RN Chem Commun (Camb); 2018 May; 54(36):4593-4596. PubMed ID: 29670956 [TBL] [Abstract][Full Text] [Related]
46. The solution structure of rat Abeta-(1-28) and its interaction with zinc ion: insights into the scarcity of amyloid deposition in aged rat brain. Huang J; Yao Y; Lin J; Ye YH; Sun WY; Tang Dagger WX J Biol Inorg Chem; 2004 Jul; 9(5):627-35. PubMed ID: 15160315 [TBL] [Abstract][Full Text] [Related]
47. Comparison of the aggregation properties, secondary structure and apoptotic effects of wild-type, Flemish and Dutch N-terminally truncated amyloid beta peptides. Demeester N; Mertens C; Caster H; Goethals M; Vandekerckhove J; Rosseneu M; Labeur C Eur J Neurosci; 2001 Jun; 13(11):2015-24. PubMed ID: 11422442 [TBL] [Abstract][Full Text] [Related]
48. Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Kakio A; Nishimoto S; Yanagisawa K; Kozutsumi Y; Matsuzaki K Biochemistry; 2002 Jun; 41(23):7385-90. PubMed ID: 12044171 [TBL] [Abstract][Full Text] [Related]
49. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice. Sadowski M; Pankiewicz J; Scholtzova H; Ripellino JA; Li Y; Schmidt SD; Mathews PM; Fryer JD; Holtzman DM; Sigurdsson EM; Wisniewski T Am J Pathol; 2004 Sep; 165(3):937-48. PubMed ID: 15331417 [TBL] [Abstract][Full Text] [Related]
50. PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer's disease. Brambilla D; Verpillot R; Le Droumaguet B; Nicolas J; Taverna M; Kóňa J; Lettiero B; Hashemi SH; De Kimpe L; Canovi M; Gobbi M; Nicolas V; Scheper W; Moghimi SM; Tvaroška I; Couvreur P; Andrieux K ACS Nano; 2012 Jul; 6(7):5897-908. PubMed ID: 22686577 [TBL] [Abstract][Full Text] [Related]
51. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Butterfield DA; Reed T; Newman SF; Sultana R Free Radic Biol Med; 2007 Sep; 43(5):658-77. PubMed ID: 17664130 [TBL] [Abstract][Full Text] [Related]
52. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease? Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267 [TBL] [Abstract][Full Text] [Related]
54. Selective binding of tumor suppressor p53 protein to topologically constrained DNA: Modulation by intercalative drugs. Pivonková H; Sebest P; Pecinka P; Tichá O; Nemcová K; Brázdová M; Jagelská EB; Brázda V; Fojta M Biochem Biophys Res Commun; 2010 Mar; 393(4):894-9. PubMed ID: 20175992 [TBL] [Abstract][Full Text] [Related]
55. Crown ethers attenuate aggregation of amyloid beta of Alzheimer's disease. Tian Y; Zhang X; Li Y; Shoup TM; Teng X; Elmaleh DR; Moore A; Ran C Chem Commun (Camb); 2014 Dec; 50(99):15792-5. PubMed ID: 25372154 [TBL] [Abstract][Full Text] [Related]
56. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding. Xu L; Chen Y; Wang X Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638 [TBL] [Abstract][Full Text] [Related]
57. Role of the region 23-28 in Abeta fibril formation: insights from simulations of the monomers and dimers of Alzheimer's peptides Abeta40 and Abeta42. Melquiond A; Dong X; Mousseau N; Derreumaux P Curr Alzheimer Res; 2008 Jun; 5(3):244-50. PubMed ID: 18537541 [TBL] [Abstract][Full Text] [Related]
58. Free Heme and Amyloid-β: A Fatal Liaison in Alzheimer's Disease. Chiziane E; Telemann H; Krueger M; Adler J; Arnhold J; Alia A; Flemmig J J Alzheimers Dis; 2018; 61(3):963-984. PubMed ID: 29332049 [TBL] [Abstract][Full Text] [Related]